Caseware UK (AP4) 2022.0.179 2022.0.179 2023-03-312023-03-312No description of principal activityfalse22022-04-01falseThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006. 10832779 2022-04-01 2023-03-31 10832779 2021-04-01 2022-03-31 10832779 2023-03-31 10832779 2022-03-31 10832779 c:Director2 2022-04-01 2023-03-31 10832779 d:CurrentFinancialInstruments 2023-03-31 10832779 d:CurrentFinancialInstruments 2022-03-31 10832779 d:Non-currentFinancialInstruments 2023-03-31 10832779 d:Non-currentFinancialInstruments 2022-03-31 10832779 c:AuditExempt-NoAccountantsReport 2022-04-01 2023-03-31 10832779 c:FullAccounts 2022-04-01 2023-03-31 10832779 c:PrivateLimitedCompanyLtd 2022-04-01 2023-03-31 10832779 c:Micro-entities 2022-04-01 2023-03-31 iso4217:GBP xbrli:pure

Registered number: 10832779









KKS PHARMA ENTERPRISE LTD







UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 31 MARCH 2023

 
KKS PHARMA ENTERPRISE LTD
REGISTERED NUMBER: 10832779

BALANCE SHEET
AS AT 31 MARCH 2023

2023
2022
£
£


Fixed assets
165,000
165,000

Current assets
4,511
3,947

Creditors: amounts falling due within one year
(68,047)
(63,062)

Net current liabilities
 
 
(63,536)
 
 
(59,115)

Total assets less current liabilities
101,464
105,885

Creditors: amounts falling due after more than one year
(91,326)
(98,401)


Net assets
10,138
7,484



Capital and reserves
10,138
7,484


Notes


General information

KKS Pharma Enterprise Ltd is a private company, limited by shares, registered in England and Wales. The address of the Company’s registered office is 27 Esingdon Drive, Thame, Oxfordshire, OX9 3DS.
The financial statements are presented in sterling which is the functional currency of the Company and rounded to the nearest £.


Average number of employees

The average monthly number of employees, including directors, during the year was 2 (2022 - 2).


Directors' confirmations

The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared in accordance with the provisions applicable to entities subject to the micro-entities' regime.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

Page 1

 
KKS PHARMA ENTERPRISE LTD
REGISTERED NUMBER: 10832779
    
BALANCE SHEET (CONTINUED)
AS AT 31 MARCH 2023

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 




................................................
S Patel
Director
Date: 19 October 2023

 
Page 2